Company intelligence / Profile preview

IPMD

Albany, California, United States

Ownership: Private
Employees: ~32
Development stage: Other

Overview

IPMD has developed an emotional AI platform that detects facial and micro-facial expressions to assess patient emotional states during telemedicine encounters. The platform achieved 95% ROC/AUC in emotion detection, outperforming Microsoft's model[1]. EchoAI was officially launched as a mobile app in 2025 with real-time emotional feedback capabilities[1].

Therapeutic areas: PsychiatryOther
Modalities: Software/AI Platform
Industry: Digital Health Medical Devices

Partnerships

Google Cloud (technology partner since 2019, 2025 funding for RESTful API)NVIDIA (Inception Program member since 2019)AWS (Active Member since 2020)Microsoft (Startup Program since 2023)Jumpstart Foundry (JSF, pre-seed funding cohort 2023)

Beyond the preview

Go deeper on IPMD.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IPMD.

Explore the full profile